Chen Yuan, ScD; Ana Babic, PhD, MPH; Natalia Khalaf, MD, MPH; et al.
JAMA Oncol. Published online August 13, 2020. doi:10.1001/jamaoncol.2020.2948
This cohort study examines multiyear self-reported demographic, lifestyle choice, and medical history data to track weight changes, disease diagnoses, health outcomes, and other factors associated with pancreatic cancer risk among participants in 2 long-term national surveys.
Ke-Da Yu, MD, PhD; Fu-Gui Ye, MD; Min He, MD; et al.
open access
JAMA Oncol. Published online August 13, 2020. doi:10.1001/jamaoncol.2020.2965
This randomized phase 3 clinical trial evaluates the effect of a carboplatin-plus-paclitaxel regimen on survival, compared with a standard-dose regimen of cyclophosphamide, epirubicin, and fluorouracil followed by docetaxel, in women with operable triple-negative breast cancer in China.